{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:41:12Z","timestamp":1792737672509,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ijrobp.2026.02.207","type":"journal-article","created":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T23:37:06Z","timestamp":1771198626000},"page":"1345-1353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development of a National Indication Protocol for Proton Therapy in Patients With Seminoma Testis to Reduce the Risk on Subsequent Primary Cancers"],"prefix":"10.1016","volume":"126","author":[{"given":"Nienke","family":"Kuijsters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Sinnige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline A.","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shafak Al","family":"Uwini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte L.","family":"Brouwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Budiharto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob P.","family":"Coppes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"Dirkx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Franckena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Habraken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne AA","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne L.B.","family":"Klaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes A.","family":"Langendijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ada","family":"Oele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Schimmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewoud","family":"Schuit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert Jan","family":"Smeenk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Unipan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Vanneste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilma D.","family":"Heemsbergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liesbeth J.","family":"Boersma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2026.02.207_bib0001","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1200\/JCO.2017.77.4174","article-title":"Risk of solid cancer after treatment of testicular germ cell cancer in the platinum era","volume":"36","author":"Groot","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.207_bib0002","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/cncr.32538","article-title":"Platinum exposure and cause-specific mortality among patients with testicular cancer","volume":"126","author":"Groot","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2026.02.207_bib0003","unstructured":"EAU. EAU Guidelines on testicular cancer. Accessed March 3, 2025. https:\/\/uroweb.org\/guidelines\/testicular-cancer."},{"key":"10.1016\/j.ijrobp.2026.02.207_bib0004","doi-asserted-by":"crossref","first-page":"772","DOI":"10.6004\/jnccn.2015.0092","article-title":"Testicular cancer, version 2.2015","volume":"13","author":"Motzer","year":"2015","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.ijrobp.2026.02.207_bib0005","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.radonc.2009.12.002","article-title":"How costly is particle therapy? Cost analysis of external beam radiotherapy with carbon-ions, protons and photons","volume":"95","author":"Peeters","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.207_bib0006","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.radonc.2013.05.007","article-title":"Selection of patients for radiotherapy with protons aiming at reduction of side effects: The model-based approach","volume":"107","author":"Langendijk","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.207_bib0007","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.semradonc.2017.11.008","article-title":"Clinical trial strategies to compare protons with photons","volume":"28","author":"Langendijk","year":"2018","journal-title":"J Sem Rad Onc"},{"key":"10.1016\/j.ijrobp.2026.02.207_bib0008","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.ijrobp.2012.11.006","article-title":"Protons in head-and-neck cancer: Bridging the gap of evidence","volume":"85","author":"Ramaekers","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.02.207_bib0009","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.clon.2021.12.007","article-title":"Model-based selection for proton therapy in breast cancer: Development of the National Indication Protocol for Proton Therapy and first clinical experiences","volume":"34","author":"Boersma","year":"2022","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ijrobp.2026.02.207_bib0010","doi-asserted-by":"crossref","first-page":"354","DOI":"10.14338\/IJPT-20-00089.1","article-title":"National protocol for model-based selection for proton therapy in head and neck cancer","volume":"8","author":"Langendijk","year":"2021","journal-title":"Int J Part Ther"},{"key":"10.1016\/j.ijrobp.2026.02.207_bib0011","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.radonc.2020.11.004","article-title":"Dutch Society for Radiation Oncology NVRO: Proton therapy for selected low grade glioma patients in the Netherlands","volume":"154","author":"van der Weide","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.207_bib0012","doi-asserted-by":"crossref","first-page":"110955","DOI":"10.1016\/j.radonc.2025.110955","article-title":"Second primary cancer risks in seminoma patients treated with current and previous radiotherapy protocols: a systematic literature review","volume":"209","author":"Heemsbergen","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.207_bib0013","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.radonc.2019.08.005","article-title":"Practical robustness evaluation in radiotherapy - A photon and proton-proof alternative to PTV-based plan evaluation","volume":"141","author":"Korevaar","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.207_bib0014","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/ijc.32704","article-title":"Continuing increased risk of second cancer in long-term testicular cancer survivors after treatment in the cisplatin era","volume":"147","author":"Hellesnes","year":"2020","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ijrobp.2026.02.207_bib0015","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/bjc.2013.551","article-title":"Second cancer risk and mortality in men treated with radiotherapy for stage I seminoma","volume":"110","author":"Horwich","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2026.02.207_bib0016","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1093\/jnci\/dji278","article-title":"Second cancers among 40,576 testicular cancer patients: Focus on long-term survivors","volume":"97","author":"Travis","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2026.02.207_bib0017","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1200\/JCO.2006.10.5296","article-title":"Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer","volume":"25","author":"Van den Belt-Dusebout","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.207_bib0018","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1093\/annonc\/mdu287","article-title":"Pancreatic cancer risk after treatment of Hodgkin lymphoma","volume":"25","author":"Dores","year":"2014","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.207_bib0019","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/bjc.2016.272","article-title":"Increased pancreatic cancer risk following radiotherapy for testicular cancer","volume":"115","author":"Hauptmann","year":"2016","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2026.02.207_bib0020","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1667\/RR14453.1","article-title":"Stomach cancer following hodgkin lymphoma, testicular cancer and cervical cancer: A pooled analysis of three international studies with a focus on radiation effects","volume":"187","author":"Gilbert","year":"2017","journal-title":"Radiat Res"},{"key":"10.1016\/j.ijrobp.2026.02.207_bib0021","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/bjc.2014.552","article-title":"Increased stomach cancer risk following radiotherapy for testicular cancer","volume":"112","author":"Hauptmann","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2026.02.207_bib0022","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1200\/JCO.2013.50.6832","article-title":"Stomach cancer risk after treatment for Hodgkin lymphoma","volume":"31","author":"Morton","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.207_bib0023","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.ijrobp.2009.01.073","article-title":"Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy","volume":"75","author":"Van den Belt-Dusebout","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.02.207_bib0024","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1667\/RR14492.1","article-title":"Solid cancer incidence among the life span study of atomic bomb survivors: 1958-2009","volume":"187","author":"Grant","year":"2017","journal-title":"Radiat Res"},{"key":"10.1016\/j.ijrobp.2026.02.207_bib0025","first-page":"140","article-title":"Radiation risks for the incidence of kidney, bladder and other urinary tract cancers: 1958\u20132009","volume":"195","author":"Grant","year":"2021","journal-title":"Radiat Res"},{"key":"10.1016\/j.ijrobp.2026.02.207_bib0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1667\/RR0763.1","article-title":"Solid cancer incidence in atomic bomb survivors: 1958-1998","volume":"168","author":"Preston","year":"2007","journal-title":"Radiat. Res."},{"key":"10.1016\/j.ijrobp.2026.02.207_bib0027","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.juro.2015.06.092","article-title":"Risk of a second kidney carcinoma following childhood cancer: Role of chemotherapy and radiation dose to kidneys","volume":"194","author":"Valtaire","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2026.02.207_bib0028","article-title":"Toxicities associated with cisplatin-based chemotherapy and radiotherapy in long-term testicular cancer survivors (review)","volume":"18","author":"Fung","year":"2018","journal-title":"Adv Urol"},{"key":"10.1016\/j.ijrobp.2026.02.207_bib0029","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.6004\/jnccn.2019.7369","article-title":"Testicular cancer survivorship (review)","volume":"17","author":"Fung","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.ijrobp.2026.02.207_bib0030","first-page":"373","article-title":"Exploring the spectrum of late effects following radical orchidectomy for stage I testicular seminoma: A systematic review of the literature","volume":"27","author":"Soon","year":"2019","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ijrobp.2026.02.207_bib0031","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/0284186X.2020.1724328","article-title":"Longitudinal kidney function outcome in aging testicular cancer survivors","volume":"59","author":"Nome","year":"2020","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.207_bib0032","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1200\/JCO.2010.29.9362","article-title":"Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: A 20-year follow-up study","volume":"28","author":"Haugnes","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.207_bib0033","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/jnci\/djz152","article-title":"Radiation dose and volume to the pancreas and subsequent risk of diabetes mellitus: A report from the childhood cancer survivor study","volume":"112","author":"Friedman","year":"2020","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2026.02.207_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2022.11.021","article-title":"Clues to address barriers for access to proton therapy in the Netherlands","volume":"178","author":"Thijssen","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.207_bib0035","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.radonc.2007.12.003","article-title":"Secondary neutrons in clinical proton radiotherapy: A charged issue","volume":"86","author":"Brenner","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.207_bib0036","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ejmp.2017.05.002","article-title":"Special radiobiological features of second cancer risk after particle radiotherapy","volume":"42","author":"Trott","year":"2017","journal-title":"Phys Med"},{"key":"10.1016\/j.ijrobp.2026.02.207_bib0037","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ijrobp.2008.09.030","article-title":"Out-of-field dose equivalents delivered by passively scattered therapeutic proton beams for clinically relevant field configurations","volume":"73","author":"Wroe","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.02.207_bib0038","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijrobp.2013.04.030","article-title":"Incidence of second malignancies among patients treated with proton versus photon radiation","volume":"87","author":"Chung","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.02.207_bib0039","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1002\/cncr.32938","article-title":"Second cancer risk after primary cancer treatment with three-dimensional conformal, intensity-modulated, or proton beam radiation therapy","volume":"126","author":"Xiang","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2026.02.207_bib0040","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.radonc.2012.12.002","article-title":"Mapping patterns of nodal metastases in seminoma: Rethinking radiotherapy fields","volume":"106","author":"Paly","year":"2013","journal-title":"Radiother Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626003937?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626003937?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:32:25Z","timestamp":1792737145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301626003937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0360301626003937"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.02.207","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a National Indication Protocol for Proton Therapy in Patients With Seminoma Testis to Reduce the Risk on Subsequent Primary Cancers","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.02.207","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}